Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November…
Clinical
OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the…
Commercial
BioSpace Movers & Shakers, Oct. 30
Commercial
Q32 Stays Busy with $60 Million Series B and First Dose…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide…
Commercial
Oyster Point Pharma to Report Third Quarter 2020 Financial Results on…
Clinical
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Trevena, Inc. Announces DEA Scheduling of OLINVYK (oliceridine) injection – FirstWord…
Home
Clinical
Phase IV
Phase IV
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase IV
First Patient Enrolled in Mallinckrodt Phase 4 Trial of Acthar Gel (Repository Corticotropin Injection) for Severe Keratitis
Firstwordpharma News
-
December 16, 2019
- Advertisement -
MOST POPULAR
Insys Therapeutics Files for Bankruptcy Following Legal Trouble
June 10, 2019
CNS Pharmaceuticals Announces Business Highlights and 2019 Fourth Quarter Financial Results
March 12, 2020
MMS Holdings Doubles Growth in South Africa Region Amid Burgeoning Pharmaceutical...
November 20, 2019
Cytokinetics’ ALS Treatment Fails to Hit Endpoints in Phase II, Company...
May 6, 2019
Load more
HOT NEWS
Newer Targets
Preclinical Data Shows Combination Immunotherapy Could Stop Liver Cancer Growth
Acquisitions
Parexel Announces Acquisition of Leading Pharmacology Modeling & Analytics Modeling Firm...
Commercial
Inventiva annonce la suspension temporaire du cours de ses actions ordinaires...
Commercial
Dicerna Bolsters Leadership Team to Support Continued Growth
